Wang D S, Huang W, Yuan M, Shi J Q
Cancer Research Laboratory, Center for Experimental Medicine, Beijing 514 Hospital.
Chin Med J (Engl). 1992 Nov;105(11):905-8.
The levels of tumor-associated antigens (TAAS) corresponded to monoclonal antibodies WLA-2C4 and CL-3 in sera of 57 lung cancer patients, 100 healthy adults and 50 non-tumor disease patients were assayed with SABC-ELISA of immunobinding inhibition test. The threshold values of WLA-2C4 and CL-3 (RBI) were 12% and 36%, respectively. The positive results of lung carcinomas with at least one of the two TAAS were as follows: squamous cell carcinoma 89%; adenocarcinoma 83%; small cell carcinoma 67% and their mean positive rate was 79%. Whereas the positive rate in healthy adults and non-tumor disease patients was only 6%. These results indicate that using monoclonal antibodies WLA-2C4 and CL-3 simultaneously may be helpful to the serological diagnosis of lung carcinoma.
采用免疫结合抑制试验的SABC - ELISA法检测了57例肺癌患者、100例健康成年人和50例非肿瘤疾病患者血清中与单克隆抗体WLA - 2C4和CL - 3相对应的肿瘤相关抗原(TAAs)水平。WLA - 2C4和CL - 3的阈值(RBI)分别为12%和36%。两种TAAs中至少有一种呈阳性的肺癌结果如下:鳞状细胞癌89%;腺癌83%;小细胞癌67%,其平均阳性率为79%。而健康成年人和非肿瘤疾病患者的阳性率仅为6%。这些结果表明,同时使用单克隆抗体WLA - 2C4和CL - 3可能有助于肺癌的血清学诊断。